Charles K. Gayer

Insider Reports History

Location
Durham, NC
Signature
/s/ Alane P. Barnes, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles K. Gayer:

Company Role Class Num Shares Value Price $ Report Date Ownership
BIOCRYST PHARMACEUTICALS INC President and CCO Common Stock 418,827 $3,170,520 $7.57 12 Dec 2025 Direct
BIOCRYST PHARMACEUTICALS INC President and CCO Emp. Stock Option (Right to Buy) 0 22 Dec 2025 Direct

Insider Reports Filed by Charles K. Gayer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BCRX BIOCRYST PHARMACEUTICALS INC 19 Dec 2025 7 +$286,851 4 President and CCO 23 Dec 2025, 16:08
BCRX BIOCRYST PHARMACEUTICALS INC 17 Dec 2025 2 $0 4 President and CCO 19 Dec 2025, 16:20
BCRX BIOCRYST PHARMACEUTICALS INC 12 Dec 2025 1 -$61,930 4 President and CCO 16 Dec 2025, 16:21
BCRX BIOCRYST PHARMACEUTICALS INC 19 Dec 2024 3 -$18,187 4 Chief Commercial Officer 23 Dec 2024, 16:19
BCRX BIOCRYST PHARMACEUTICALS INC 14 Dec 2024 1 -$62,130 4 Chief Commercial Officer 17 Dec 2024, 16:22
BCRX BIOCRYST PHARMACEUTICALS INC 13 May 2024 1 +$164,100 4 Chief Commercial Officer 15 May 2024, 07:04
BCRX BIOCRYST PHARMACEUTICALS INC 19 Dec 2023 1 -$15,016 4 Chief Commercial Officer 20 Dec 2023, 16:38
BCRX BIOCRYST PHARMACEUTICALS INC 14 Dec 2023 3 -$37,551 4 Chief Commercial Officer 18 Dec 2023, 16:40
BCRX BIOCRYST PHARMACEUTICALS INC 19 Dec 2022 2 $0 4 Chief Commercial Officer 21 Dec 2022, 15:34
BCRX BIOCRYST PHARMACEUTICALS INC 15 Dec 2022 1 -$66,490 4 Chief Commercial Officer 19 Dec 2022, 15:48
BCRX BIOCRYST PHARMACEUTICALS INC 14 Dec 2021 1 $0 4/A Chief Commercial Officer 13 Jan 2022, 15:38